Enterohaemorrhagic Escherichia coli (EHEC), a major foodborne pathogen, is responsible for life-threatening diseases in humans as a consequence of the production of Shiga-like toxins. Currently, there is no specific treatment for EHEC infection and the use of antibiotics is contraindicated. Moreover, lack of a good animal model system hinders the study of EHEC virulence with systematic methods in vivo. To these regards, we applied the genetic tractable animal model, Caenorhabditis elegans, as a surrogate host to study the virulence of EHEC as well as the host innate immunity to this human pathogen. Our results show that E. coli O157:H7, a serotype of EHEC, infects and kills C. elegans. We also demonstrate that E. coli O157:H7 colonizes and replicates in C. elegans, stimulates the ectopic expression of microvillar actin, and induces the characteristic attaching and effacing (A/E) lesions in the intact intestinal epithelium in vivo. Moreover, our genetic analyses corroborate that the Shiga-like toxin 1 (Stx1) of E. coli O157:H7 is required partly for its toxicity. The C. elegans
p38 MAP kinase signaling pathways, an evolutionally conserved innate immune signaling pathways, are activated and mediated in the regulation of host susceptibility to EHEC infection in a Stx1-dependent manner. Given that the bacterivore C. elegans and bacterium, in this case E. coli, may have generated a diverse arsenal for both parties to defend each other during the long-term evolution of this predator-prey relationship, our results suggest that this EHEC-C. elegans model is suitable for future comprehensive genetic screens for both novel bacterial and host factors involved in the pathogenesis of EHEC infection.